Literature DB >> 24043806

Wnt signaling potentiates nevogenesis.

Jeff S Pawlikowski1, Tony McBryan, John van Tuyn, Mark E Drotar, Rachael N Hewitt, Andrea B Maier, Ayala King, Karen Blyth, Hong Wu, Peter D Adams.   

Abstract

Cellular senescence is a stable proliferation arrest associated with an altered secretory pathway (senescence-associated secretory phenotype). Cellular senescence is also a tumor suppressor mechanism, to which both proliferation arrest and senescence-associated secretory phenotype are thought to contribute. The melanocytes within benign human nevi are a paradigm for tumor-suppressive senescent cells in a premalignant neoplasm. Here a comparison of proliferating and senescent melanocytes and melanoma cell lines by RNA sequencing emphasizes the importance of senescence-associated proliferation arrest in suppression of transformation. Previous studies showed that activation of the Wnt signaling pathway can delay or bypass senescence. Consistent with this, we present evidence that repression of Wnt signaling contributes to melanocyte senescence in vitro. Surprisingly, Wnt signaling is active in many senescent human melanocytes in nevi, and this is linked to histological indicators of higher proliferative and malignant potential. In a mouse, activated Wnt signaling delays senescence-associated proliferation arrest to expand the population of senescent oncogene-expressing melanocytes. These results suggest that Wnt signaling can potentiate nevogenesis in vivo by delaying senescence. Further, we suggest that activated Wnt signaling in human nevi undermines senescence-mediated tumor suppression and enhances the probability of malignancy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24043806      PMCID: PMC3791768          DOI: 10.1073/pnas.1303491110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  54 in total

1.  Screening of N-ras codon 61 mutations in paired primary and metastatic cutaneous melanomas: mutations occur early and persist throughout tumor progression.

Authors:  Katarina Omholt; Sofia Karsberg; Anton Platz; Lena Kanter; Ulrik Ringborg; Johan Hansson
Journal:  Clin Cancer Res       Date:  2002-11       Impact factor: 12.531

2.  Loss of beta-catenin expression associated with disease progression in malignant melanoma.

Authors:  T Kageshita; C V Hamby; T Ishihara; K Matsumoto; T Saida; T Ono
Journal:  Br J Dermatol       Date:  2001-08       Impact factor: 9.302

3.  Neural crest-directed gene transfer demonstrates Wnt1 role in melanocyte expansion and differentiation during mouse development.

Authors:  K J Dunn; B O Williams; Y Li; W J Pavan
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

4.  Wnt signaling controls the phosphorylation status of beta-catenin.

Authors:  Mascha van Noort; Jan Meeldijk; Ruurd van der Zee; Olivier Destree; Hans Clevers
Journal:  J Biol Chem       Date:  2002-02-07       Impact factor: 5.157

5.  High frequency of BRAF mutations in nevi.

Authors:  Pamela M Pollock; Ursula L Harper; Katherine S Hansen; Laura M Yudt; Mitchell Stark; Christiane M Robbins; Tracy Y Moses; Galen Hostetter; Urs Wagner; John Kakareka; Ghadi Salem; Tom Pohida; Peter Heenan; Paul Duray; Olli Kallioniemi; Nicholas K Hayward; Jeffrey M Trent; Paul S Meltzer
Journal:  Nat Genet       Date:  2002-11-25       Impact factor: 38.330

6.  Nuclear parameters in the superficial and deep portion of melanocytic lesions--a morphometrical investigation.

Authors:  J Smolle; H P Soyer; F M Juettner; S Hoedl; H Kerl
Journal:  Pathol Res Pract       Date:  1988-06       Impact factor: 3.250

7.  Brn-2 expression controls melanoma proliferation and is directly regulated by beta-catenin.

Authors:  Jane Goodall; Silvia Martinozzi; Timothy J Dexter; Delphine Champeval; Suzanne Carreira; Lionel Larue; Colin R Goding
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

8.  Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence.

Authors:  Masashi Narita; Sabrina Nũnez; Edith Heard; Masako Narita; Athena W Lin; Stephen A Hearn; David L Spector; Gregory J Hannon; Scott W Lowe
Journal:  Cell       Date:  2003-06-13       Impact factor: 41.582

9.  Beta-catenin-induced melanoma growth requires the downstream target Microphthalmia-associated transcription factor.

Authors:  Hans R Widlund; Martin A Horstmann; E Roydon Price; Junqing Cui; Stephen L Lessnick; Min Wu; Xi He; David E Fisher
Journal:  J Cell Biol       Date:  2002-09-16       Impact factor: 10.539

10.  Lysosome-mediated processing of chromatin in senescence.

Authors:  Andre Ivanov; Jeff Pawlikowski; Indrani Manoharan; John van Tuyn; David M Nelson; Taranjit Singh Rai; Parisha P Shah; Graeme Hewitt; Viktor I Korolchuk; Joao F Passos; Hong Wu; Shelley L Berger; Peter D Adams
Journal:  J Cell Biol       Date:  2013-07-01       Impact factor: 10.539

View more
  30 in total

1.  A Systematic Evaluation of Methods for Tailoring Genome-Scale Metabolic Models.

Authors:  Sjoerd Opdam; Anne Richelle; Benjamin Kellman; Shanzhong Li; Daniel C Zielinski; Nathan E Lewis
Journal:  Cell Syst       Date:  2017-02-15       Impact factor: 10.304

2.  dNTP metabolism links mechanical cues and YAP/TAZ to cell growth and oncogene-induced senescence.

Authors:  Giulia Santinon; Irene Brian; Arianna Pocaterra; Patrizia Romani; Elisa Franzolin; Chiara Rampazzo; Silvio Bicciato; Sirio Dupont
Journal:  EMBO J       Date:  2018-04-12       Impact factor: 11.598

3.  Senescence induction universally activates transposable element expression.

Authors:  Anthony R Colombo; Harold K Elias; Giridharan Ramsingh
Journal:  Cell Cycle       Date:  2018-08-16       Impact factor: 4.534

4.  FOXQ1 controls the induced differentiation of melanocytic cells.

Authors:  Archis Bagati; Anna Bianchi-Smiraglia; Sudha Moparthy; Kateryna Kolesnikova; Emily E Fink; Masha Kolesnikova; Matthew V Roll; Peter Jowdy; David W Wolff; Anthony Polechetti; Dong Hyun Yun; Brittany C Lipchick; Leslie M Paul; Brian Wrazen; Kalyana Moparthy; Shaila Mudambi; Galina E Morozevich; Sofia G Georgieva; Jianmin Wang; Gal Shafirstein; Song Liu; Eugene S Kandel; Albert E Berman; Neil F Box; Gyorgy Paragh; Mikhail A Nikiforov
Journal:  Cell Death Differ       Date:  2018-02-20       Impact factor: 15.828

5.  Senescent human melanocytes drive skin ageing via paracrine telomere dysfunction.

Authors:  Stella Victorelli; Anthony Lagnado; Jessica Halim; Will Moore; Duncan Talbot; Karen Barrett; James Chapman; Jodie Birch; Mikolaj Ogrodnik; Alexander Meves; Jeff S Pawlikowski; Diana Jurk; Peter D Adams; Diana van Heemst; Marian Beekman; P Eline Slagboom; David A Gunn; João F Passos
Journal:  EMBO J       Date:  2019-10-21       Impact factor: 11.598

6.  Senescence-associated reprogramming promotes cancer stemness.

Authors:  Maja Milanovic; Dorothy N Y Fan; Dimitri Belenki; J Henry M Däbritz; Zhen Zhao; Yong Yu; Jan R Dörr; Lora Dimitrova; Dido Lenze; Ines A Monteiro Barbosa; Marco A Mendoza-Parra; Tamara Kanashova; Marlen Metzner; Katharina Pardon; Maurice Reimann; Andreas Trumpp; Bernd Dörken; Johannes Zuber; Hinrich Gronemeyer; Michael Hummel; Gunnar Dittmar; Soyoung Lee; Clemens A Schmitt
Journal:  Nature       Date:  2017-12-20       Impact factor: 49.962

7.  A decline in Wnt3a signaling is necessary for mesenchymal stem cells to proceed to replicative senescence.

Authors:  Ji Yung Jeoung; Hae Yun Nam; Jihye Kwak; Hye Jin Jin; Hyang Ju Lee; Byoung Wook Lee; Jong Hyeok Baek; Jin Sup Eom; Eun-Ju Chang; Dong-Myung Shin; Soo Jin Choi; Seong Who Kim
Journal:  Stem Cells Dev       Date:  2015-01-08       Impact factor: 3.272

8.  P16INK4a Positive Cells in Human Skin Are Indicative of Local Elastic Fiber Morphology, Facial Wrinkling, and Perceived Age.

Authors:  Mariëtte E C Waaijer; David A Gunn; Peter D Adams; Jeff S Pawlikowski; Christopher E M Griffiths; Diana van Heemst; P Eline Slagboom; Rudi G J Westendorp; Andrea B Maier
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2015-08-18       Impact factor: 6.053

9.  Senescence Elicits Stemness: A Surprising Mechanism for Cancer Relapse.

Authors:  Zhixun Dou; Shelley L Berger
Journal:  Cell Metab       Date:  2018-04-03       Impact factor: 27.287

10.  The biological effect and mechanism of the Wnt/β-catenin signaling pathway on malignant melanoma A375 cells.

Authors:  Yuxia Lin; Fangfei Wang; Qingfei Xing; Feng Guo; Mengzhen Wang; Yunjie Li
Journal:  Exp Ther Med       Date:  2018-07-06       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.